Insider Trading activities of Incyte Corp insiders. , Part 3

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Incyte Corp since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Incyte Corp since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Incyte Corp since 2005. The reporting company's ticker symbol is INCY. The reporting company's CIK number is 879169.
The total value of stock buying since 2005 is $313,711,766.
The total value of stock sales since 2005 is $511,257,729.
The total value of stock option exercises since 2005 is $88,892,729.


 1   2   3 

Table 2. Detailed insider stock purchases, sales, and option exercises of Incyte Corp insiders (INCY) , Part 3
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2014-02-13 Swain Paula J (EVP, Human Resources) Option Ex 216,967 10.70 2,322,197
2014-02-13 Ariko Barry A (Director) Sale 10,000 66.49 664,900
2014-02-13 Ariko Barry A (Director) Option Ex 10,000 7.02 70,200
2013-12-17 Whitfield Roy A (Director) Option Ex 45,000 7.32 329,400
2013-11-18 Whitfield Roy A (Director) Sale 50,000 47.37 2,368,500
2013-09-10 Friedman Paul A (Chief Executive Officer) Sale 376,789 37.32 14,061,765
2013-09-10 Friedman Paul A (Chief Executive Officer) Option Ex 376,789 8.12 3,060,657
2013-09-09 Chardonnet Laurent (Other) Sale 36,067 37.90 1,366,939
2013-09-06 Siegel Eric H. (EVP, General Counsel) Sale 55,978 35.17 1,968,746
2013-09-06 Siegel Eric H. (EVP, General Counsel) Option Ex 55,978 15.79 884,060
2013-09-06 Levy Richard S (EVP, Chief Drug Dev&Medical Of) Sale 25,000 35.28 882,000
2013-09-06 Levy Richard S (EVP, Chief Drug Dev&Medical Of) Option Ex 25,000 11.98 299,500
2013-09-06 Hastings David C (Chief Financial Officer) Sale 100,000 35.16 3,515,999
2013-09-06 Hastings David C (Chief Financial Officer) Option Ex 100,000 7.09 709,000
2013-09-05 Chardonnet Laurent (Other) Sale 8,767 34.90 305,968
2013-09-05 Chardonnet Laurent (Other) Option Ex 41,800 8.18 342,049
2013-09-05 Swain Paula J (EVP, Human Resources) Sale 94,444 35.06 3,311,206
2013-09-05 Swain Paula J (EVP, Human Resources) Option Ex 94,444 7.09 669,607
2013-08-19 Whitfield Roy A (Director) Sale 50,000 26.70 1,335,000
2013-06-11 14159, L.p. (Director) Option Ex 30,000 4.44 133,200
2013-05-17 Whitfield Roy A (Director) Sale 40,000 23.08 923,199
2013-05-13 Levy Richard S (EVP, Chief Drug Dev&Medical Of) Sale 55,699 22.30 1,242,087
2013-05-13 Levy Richard S (EVP, Chief Drug Dev&Medical Of) Option Ex 60,000 7.09 425,400
2013-05-06 Friedman Paul A (Chief Executive Officer) Option Ex 23,700 12.36 293,003
2013-04-05 Ariko Barry A (Director) Option Ex 10,000 4.44 44,400
2013-03-14 Whitfield Roy A (Director) Sale 10,000 25.08 250,799
2013-03-01 Whitfield Roy A (Director) Sale 10,000 22.56 225,600
2013-02-28 Siegel Eric H. (EVP, General Counsel) Sale 50,000 22.16 1,108,000
2013-02-28 Siegel Eric H. (EVP, General Counsel) Option Ex 50,000 15.97 798,300
2013-02-27 Brooke Paul A (Director) Option Ex 10,000 4.44 44,400
2013-02-20 Swain Paula J (EVP, Human Resources) Sale 103,283 21.53 2,223,682
2013-02-20 Swain Paula J (EVP, Human Resources) Option Ex 103,283 6.83 704,906
2013-02-19 Whitfield Roy A (Director) Sale 30,000 21.82 654,600
2013-02-15 Levy Richard S (EVP, Chief Drug Dev&Medical Of) Sale 98,440 22.48 2,212,931
2013-02-15 Levy Richard S (EVP, Chief Drug Dev&Medical Of) Option Ex 98,440 6.64 653,346
2013-02-15 Hastings David C (Chief Financial Officer) Sale 100,000 22.52 2,252,000
2013-02-15 Hastings David C (Chief Financial Officer) Option Ex 100,000 7.62 762,200
2012-12-17 De Schutter Richard U (Director) Buy 45,000 16.11 724,950
2012-12-17 De Schutter Richard U (Director) Sale 50,000 16.03 801,500
2012-08-01 Baker Julian (Director) Option Ex 10,000 5.67 56,700
2012-07-12 Ariko Barry A (Director) Option Ex 10,000 5.67 56,700
2012-07-10 Friedman Paul A (Chief Executive Officer) Option Ex 25,186 7.67 193,277
2012-07-05 Chardonnet Laurent (Other) Sale 35,700 25.11 896,605
2012-07-05 Chardonnet Laurent (Other) Option Ex 35,700 7.09 253,113
2012-07-02 Chardonnet Laurent (Other) Sale 36,666 24.15 885,483
2012-07-02 Chardonnet Laurent (Other) Option Ex 36,666 6.95 254,828
2012-06-04 Baker Julian (Director) Option Ex 5,000 6.66 33,300
2012-05-24 Whitfield Roy A (Director) Sale 20,000 22.27 445,400
2012-05-17 Ariko Barry A (Director) Option Ex 5,000 6.66 33,300
2012-05-16 Brooke Paul A (Director) Sale 5,000 23.55 117,750
2012-05-16 Brooke Paul A (Director) Option Ex 5,000 6.66 33,300
2012-05-14 Siegel Eric H. (EVP, General Counsel) Sale 57,481 23.12 1,328,788
2012-05-14 Siegel Eric H. (EVP, General Counsel) Option Ex 56,666 16.01 907,392
2012-05-11 Swain Paula J (EVP, Human Resources) Sale 147,389 23.22 3,422,372
2012-05-11 Swain Paula J (EVP, Human Resources) Option Ex 147,389 7.58 1,117,650
2012-05-07 Friedman Paul A (Chief Executive Officer) Sale 225,000 22.56 5,076,000
2012-05-07 Friedman Paul A (Chief Executive Officer) Option Ex 225,000 5.97 1,343,250
2012-05-01 Chardonnet Laurent (Other) Sale 13,976 22.70 317,255
2012-04-27 Levy Richard S (EVP, Chief Drug Dev&Medical Of) Sale 30,000 22.95 688,500
2012-04-27 Levy Richard S (EVP, Chief Drug Dev&Medical Of) Option Ex 30,000 8.72 261,690
2012-03-21 Whitfield Roy A (Director) Option Ex 14,000 4.15 58,100
2012-03-19 Whitfield Roy A (Director) Option Ex 36,000 3.33 119,880
2012-02-17 Whitfield Roy A (Director) Sale 20,000 17.53 350,600
2012-01-31 De Schutter Richard U (Director) Option Ex 65,000 6.10 396,500
2012-01-19 Brooke Paul A (Director) Buy 25,000 17.86 446,500
2012-01-18 Brooke Paul A (Director) Buy 25,000 17.53 438,250
2012-01-13 Baker Felix (Director) Buy 223,367 16.55 3,697,170
2012-01-12 Baker Felix (Director) Buy 334,497 16.29 5,450,294
2011-12-09 Baker Felix (Director) Buy 186,063 13.22 2,460,682
2011-12-08 Baker Felix (Director) Buy 228,285 13.45 3,071,346
2011-12-07 Baker Felix (Director) Buy 148,781 13.22 1,966,586
2011-12-06 Baker Felix (Director) Buy 347,463 13.53 4,701,174
2011-12-05 Baker Felix (Director) Buy 1,100,510 13.88 15,276,178
2011-12-01 Baker Felix (Director) Buy 851,002 14.11 12,003,382
2011-11-30 Baker Felix (Director) Buy 507,911 13.44 6,828,355
2011-11-29 Baker Felix (Director) Buy 1,098,536 12.21 13,414,222
2011-11-17 Dixon Wendy L (Director) Buy 7,500 13.39 100,447
2011-06-21 Chardonnet Laurent (Other) Sale 40,000 18.64 745,600
2011-06-21 Chardonnet Laurent (Other) Option Ex 40,000 5.46 218,400
2011-06-17 Whitfield Roy A (Director) Sale 15,498 18.04 279,583
2011-06-16 Whitfield Roy A (Director) Sale 4,502 18.02 81,126
2011-06-09 Hastings David C (Chief Financial Officer) Sale 100,000 17.73 1,773,500
2011-06-09 Hastings David C (Chief Financial Officer) Option Ex 100,000 5.12 512,000
2011-05-17 Swain Paula J (EVP, Human Resources) Sale 75,000 19.30 1,447,500
2011-05-17 Swain Paula J (EVP, Human Resources) Option Ex 75,000 13.80 1,035,000
2011-05-12 Whitfield Roy A (Director) Sale 10,000 20.21 202,140
2011-05-11 Whitfield Roy A (Director) Sale 10,000 20.02 200,200
2011-05-10 Schreck Patricia A (EVP, General Counsel) Sale 50,000 20.58 1,029,100
2011-05-10 Schreck Patricia A (EVP, General Counsel) Option Ex 50,000 5.46 273,000
2011-05-09 Schreck Patricia A (EVP, General Counsel) Sale 50,000 19.90 994,999
2011-05-09 Schreck Patricia A (EVP, General Counsel) Option Ex 50,000 6.15 307,500
2011-05-09 Whitfield Roy A (Director) Sale 10,000 19.78 197,800
2011-05-06 Chardonnet Laurent (Other) Sale 5,343 19.55 104,455
2011-05-05 Whitfield Roy A (Director) Sale 10,000 19.24 192,440
2011-04-11 Metcalf Brian W (Chief Drug Discovery Scientist) Sale 100,000 17.41 1,741,000
2011-04-11 Metcalf Brian W (Chief Drug Discovery Scientist) Option Ex 100,000 5.46 546,000
2011-04-08 Chardonnet Laurent (Other) Sale 25,000 17.03 425,825
2011-04-08 Chardonnet Laurent (Other) Option Ex 25,000 3.11 77,750
2011-04-07 Schreck Patricia A (EVP, General Counsel) Sale 100,000 16.50 1,650,000
2011-04-07 Schreck Patricia A (EVP, General Counsel) Option Ex 100,000 4.29 428,500
2011-04-05 Whitfield Roy A (Director) Sale 10,000 16.03 160,260
2011-03-25 Ariko Barry A (Director) Option Ex 20,834 14.13 294,384
2011-03-25 Whitfield Roy A (Director) Sale 10,000 14.70 146,950
2011-03-18 Metcalf Brian W (Chief Drug Discovery Scientist) Sale 160,000 14.28 2,284,480
2011-03-18 Metcalf Brian W (Chief Drug Discovery Scientist) Option Ex 160,000 9.79 1,565,920
2011-03-16 Metcalf Brian W (Chief Drug Discovery Scientist) Sale 50,000 14.25 712,500
2011-03-16 Metcalf Brian W (Chief Drug Discovery Scientist) Option Ex 50,000 8.52 425,750
2011-02-23 Friedman Paul A (Chief Executive Officer) Option Ex 20,000 8.64 172,800
2011-02-17 Metcalf Brian W (Chief Drug Discovery Scientist) Sale 50,000 14.35 717,500
2011-02-17 Metcalf Brian W (Chief Drug Discovery Scientist) Option Ex 50,000 5.97 298,500
2011-01-18 Levy Richard S (EVP, Chief Drug Dev&Medical Of) Sale 40,310 15.83 638,228
2011-01-18 Levy Richard S (EVP, Chief Drug Dev&Medical Of) Option Ex 40,310 6.19 249,518
2010-12-23 Whitfield Roy A (Director) Sale 10,000 17.11 171,090
2010-12-22 Whitfield Roy A (Director) Sale 10,000 17.00 170,000
2010-11-17 Whitfield Roy A (Director) Sale 1,000 15.90 15,900
2010-11-16 Whitfield Roy A (Director) Sale 10,000 16.01 160,100
2010-10-25 Whitfield Roy A (Director) Sale 29,523 16.99 501,595
2010-10-22 Whitfield Roy A (Director) Sale 4,730 16.95 80,173
2010-09-23 Baker Felix (Director) Sale 265,017 14.86 3,938,416
2010-09-22 Baker Felix (Director) Sale 334,983 14.71 4,928,268
2010-09-21 Baker Felix (Director) Sale 900,000 14.94 13,448,697
2010-08-10 Baker Felix (Director) Sale 130,190 14.00 1,822,528
2010-08-09 Chardonnet Laurent (Other) Sale 15,618 14.06 219,667
2010-08-09 Baker Felix (Director) Sale 462,666 14.08 6,516,186
2010-08-06 Schreck Patricia A (EVP, General Counsel) Sale 94,960 13.86 1,316,145
2010-08-06 Schreck Patricia A (EVP, General Counsel) Option Ex 94,960 6.15 584,004
2010-07-07 Friedman Paul A (Chief Executive Officer) Option Ex 25,142 6.28 157,766
2010-07-01 Hastings David C (Chief Financial Officer) Buy 2,000 10.24 20,480
2010-07-01 Friedman Paul A (Chief Executive Officer) Buy 10,000 10.43 104,250
2010-06-17 Swain Paula J (EVP, Human Resources) Sale 97,917 13.15 1,287,608
2010-06-17 Swain Paula J (EVP, Human Resources) Option Ex 97,917 6.12 599,252
2010-03-15 Levy Richard S (EVP, Chief Drug Dev&Medical Of) Sale 20,000 12.94 258,800
2010-03-15 Levy Richard S (EVP, Chief Drug Dev&Medical Of) Option Ex 20,000 4.19 83,800
2010-01-08 Friedman Steven M. (EVP, Biology & Preclinical Dev) Sale 22,000 10.90 239,800
2009-03-09 Friedman Paul A (Chief Executive Officer) Buy 9,400 2.10 19,740
2009-03-06 Friedman Paul A (Chief Executive Officer) Buy 10,600 2.10 22,260
2009-03-05 Friedman Paul A (Chief Executive Officer) Buy 8,840 2.20 19,448
2009-03-05 Baker Felix (Director) Buy 12,861 2.16 27,738
2009-03-03 Friedman Paul A (Chief Executive Officer) Buy 11,160 2.20 24,552
2009-03-03 Baker Felix (Director) Buy 12,090 2.14 25,882
2009-03-02 Baker Felix (Director) Buy 42,352 2.15 91,181
2008-12-19 Baker Felix (Director) Buy 384,940 3.61 1,388,091
2008-12-18 Baker Felix (Director) Buy 305,448 3.58 1,093,196
2008-12-17 Baker Felix (Director) Buy 299,251 3.27 979,147
2008-11-21 Metcalf Brian W (Chief Drug Discovery Scientist) Buy 5,000 2.19 10,925
2008-11-20 Chardonnet Laurent (Other) Buy 8,000 2.71 21,640
2008-11-20 Schreck Patricia A (EVP, General Counsel) Buy 2,500 2.44 6,097
2008-11-20 Hastings David C (Chief Financial Officer) Buy 4,000 2.36 9,440
2008-11-20 Friedman Paul A (Chief Executive Officer) Buy 13,000 2.55 33,111
2008-10-15 Friedman Paul A (Chief Executive Officer) Buy 5,300 4.60 24,379
2008-10-14 Friedman Paul A (Chief Executive Officer) Buy 4,700 5.34 25,121
2008-07-31 Baker Felix (Director) Buy 1,100,000 9.00 9,900,000
2008-01-22 Baker Felix (Director) Buy 300 10.62 3,184
2008-01-14 Baker Felix (Director) Buy 50,214 10.99 551,698
2008-01-11 Baker Felix (Director) Buy 44,500 10.94 486,649
2008-01-10 Baker Felix (Director) Buy 1,800 11.01 19,808
2008-01-09 Baker Felix (Director) Buy 131,391 10.94 1,437,678
2008-01-08 Baker Felix (Director) Buy 700,242 10.44 7,313,325
2008-01-07 Baker Felix (Director) Buy 307,890 9.48 2,919,102
2008-01-04 Baker Felix (Director) Buy 433,305 9.47 4,101,663
2007-12-19 Baker Julian (Director) Buy 129,371 10.61 1,372,237
2007-12-18 Baker Julian (Director) Buy 78,066 10.58 826,170
2007-12-17 Baker Julian (Director) Buy 137,156 10.60 1,453,165
2007-12-12 Baker Julian (Director) Buy 247,308 10.38 2,568,044
2007-12-11 Baker Julian (Director) Buy 224,000 9.86 2,208,862
2007-12-10 Baker Julian (Director) Buy 157,310 9.54 1,501,365
2007-12-04 Baker Julian (Director) Buy 80,000 8.98 718,478
2007-12-03 Baker Julian (Director) Buy 28,900 8.96 258,971
2007-11-30 Baker Julian (Director) Buy 66,544 8.59 571,611
2007-11-29 Baker Julian (Director) Buy 21,300 8.58 182,710
2007-11-28 Baker Julian (Director) Buy 155,000 8.40 1,301,378
2007-11-27 Baker Julian (Director) Buy 240,167 8.00 1,920,614
2007-11-26 Baker Julian (Director) Buy 104,154 7.94 826,772
2007-11-21 Baker Julian (Director) Buy 67,891 8.12 551,273
2007-11-20 Baker Julian (Director) Buy 95,048 8.10 769,982
2007-11-19 Baker Julian (Director) Buy 196,593 8.22 1,616,582
2007-11-16 Baker Julian (Director) Buy 138,948 8.30 1,153,545
2007-11-15 Baker Julian (Director) Buy 154,964 8.62 1,336,562
2007-11-14 Baker Julian (Director) Buy 181,211 8.53 1,546,272
2007-11-13 Baker Julian (Director) Buy 207,864 8.26 1,716,330
2007-11-13 De Schutter Richard U (Director) Option Ex 70,000 4.25 297,220
2007-11-12 Baker Julian (Director) Buy 496,116 8.18 4,059,218
2007-11-09 Baker Julian (Director) Buy 290,200 7.80 2,263,268
2007-08-17 Friedman Paul A (Chief Executive Officer) Buy 16,665 5.47 91,157
2007-08-03 Baker Julian (Director) Buy 238,596 4.83 1,151,223
2007-08-02 Baker Julian (Director) Buy 65,038 4.99 324,668
2007-08-01 Baker Julian (Director) Buy 335,075 4.95 1,657,280
2006-04-17 Metcalf Brian W (Chief Drug Discovery Scientist) Buy 5,000 3.88 19,425
2006-04-06 Swain Paula J (EVP, Human Resources) Buy 3,000 3.65 10,950
2006-04-04 Schreck Patricia A (EVP, General Counsel) Buy 2,000 3.59 7,180
2006-04-04 Hastings David C (Chief Financial Officer) Buy 2,500 3.60 9,000
2006-04-04 Friedman Paul A (Chief Executive Officer) Buy 5,500 3.56 19,580
2005-08-23 Friedman Paul A Buy 2,700 7.24 19,548
2005-03-09 De Schutter Richard U (Director) Buy 20,000 7.05 140,940
 1   2   3 

Insider trading activities including stock purchases, stock sales, and option exercises of INCY listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Incyte Corp (symbol INCY, CIK number 879169) see the Securities and Exchange Commission (SEC) website.